Combretastatin A-1
Combretastatin A-1 is a potent microtubule inhibitor with anti-tumour and anti-vascular activity, acting through microtubule protein depolymerisation-mediated inactivation of AKT to inhibit the Wnt/β-catenin pathway, and can be used to study hepatocellular carcinoma.
Product Specifications
CAS Number
109971-63-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
332.35
Molecular Formula
C18H20O6
Notes
Research use only, not for human use.
Receptor
Microtubule Associated | Akt
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
